The Chief Justice of the Victorian Supreme Court has called on the legal profession to provide more opportunities for junior counsel to hone their oral advocacy skills by make submissions or examining witnesses during hearings.
Employment law experts say the current lawsuits challenging COVID-19 vaccine mandates are likely to fail, and that future lawsuits lurking around the corner will also face a high bar.
The corporate regulator has taken MLC Limited to court, alleging the insurer’s failure to implement proper systems and controls over a more than 20 year period caused $17.5 million in harm to over a quarter million consumers.
Mayfair 101 director James Mawhinney is seeking disciplinary action against ASIC’s lawyers over a media release accusing him of breaching a 20-year ban on raising funds and which disclosed the regulator had asked a court to hold him in contempt.
A judge has indicated he will approve the ‘very low’ GetSwift class action settlement because the company appeared to be broke, but the law firm behind the case has been pulled up by the court for a previous costs estimate that has blown out by $3 million.
A judge has declined a contradictor’s calls to send an application for a common fund order in a class action against 7-Eleven, which recently settled for $98 million, to the Full Court.
A judge has scolded Slater & Gordon and two Westpac subsidiaries for a “disgraceful” privilege spat in a class action over allegedly excessive superannuation fees that he said had “gone badly off the rails”.
Clyde & Co made an “inextricable” oversight in preparing an unpaid works claim, causing a Sydney-based sandstone excavator to lose millions of dollars, according to a cross claim in a case brought by the law firm for unpaid fees.
A former partner at accounting firm Pitcher Partners has told a court that he had issues working with Ernst & Young on an audit of law firm Slater & Gordon, calling the Big 4 firm “uncooperative”.
Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
